HTA in Transition:
Delivering Value Through
Inclusive Health Policies
Tuesday, September 30th, 2025
Athens
As the European Union’s Health Technology Assessment Regulation (HTAR) came into effect in January 2025, the Annual HTA Conference in Greece, themed “HTA in Transition: Delivering Value Through Inclusive Health Policies” serves as a pivotal forum to explore the evolving landscape of health technology assessment. This year’s conference aims to address the multifaceted challenges and opportunities presented by the new regulation, emphasizing the importance of inclusive and collaborative approaches in health policy development. By bringing together diverse perspectives, the conference seeks to foster dialogue and share best practices, ensuring that the transition under the HTAR leads to more inclusive, efficient, and patient-centered health policies across Europe and Greece.
The past decade has witnessed rapid advancements in health technologies, driven by breakthroughs in genomics, digital health, and artificial intelligence. As we stand at the cusp of a new era, it is critical to evaluate and adapt our approaches to Health Technology Assessment (HTA) to ensure that innovations translate into tangible patient benefits, sustainable healthcare systems, and equitable access.
As healthcare systems across Europe navigate increasing complexity, rising costs, and evolving patient needs, we invite health representatives, industry leaders, and experts from pharmaceuticals, market access, government affairs, and health economics, to join us for a pivotal event dedicated to shaping the future of an HTA system that is robust, trusted, and aligned with both scientific progress, value-driven health policies and public interest.
Conference Highlights
- Readiness for HTAR Implementation: With the HTAR’s application, Greece is taking significant steps to strengthen National HTA capacity and bolster its HTA infrastructure. Through the TSI mechanism it aims to organize its assessment procedures, train relevant stakeholders, identify national priorities and review and amend existing laws to support the new framework. In light of these discussions will center on the progress of our country in advancing readiness for an HTA in finalizing necessary procedures, guidance, and implementing acts to ensure a functional system.
- Stakeholder Adaptation and Challenges: The conference will delve into how various stakeholders, including industry players, HTA Committee, and patient organizations, are adapting to the HTAR. Topics will include the industry’s preparation for increased PICO analyses, the role of AI in this adaptation, and the readiness for a National HTA body to utilize Joint Clinical Assessments (JCAs).
- Patient Involvement and Sustainable Input: Recognizing the crucial role of patients, sessions will explore how patient organizations are preparing for the HTAR and the factors influencing sustainable patient input in the new framework.
- Integration with Existing Initiatives: The conference will examine the HTAR’s relationship with existing regional initiatives like Beneluxa and the International Horizon Scanning Initiative (IHSI), discussing their mutual benefits and how to leverage these collaborations under the new regulation.
- The Impact of Artificial Intelligence on HTA: Artificial intelligence (AI) is revolutionizing data analysis, predictive modeling, and decision-making within HTA frameworks. Our sessions will delve into AI’s role in streamlining evaluations, improving predictive accuracy, and addressing ethical considerations, ensuring that AI-driven insights support transparent and robust assessments.
- Collaborating with Patients and Clinical Experts: The success of HTA depends on meaningful collaboration with patients and clinical experts. Their insights are invaluable for capturing real-world experiences, prioritizing outcomes, and guiding evidence generation. The conference will emphasize strategies to foster inclusive engagement, empowering stakeholders to co-create health innovations that truly meet patient needs.
Speakers
-TBA-
Panel Discussion
The Future of HTA: Inclusive, Collaborative, and Patient-Centered
Keynote Speeches
- HTA in Transition: Delivering Value Through Inclusive Health Policies
- Are We Ready for HTAR?
Main Sessions
- Health Technology Assessment in the EU Era: A Greek Perspective on Value and Access
- Real-World Impact: Mechanisms to support HTA and contain access to innovation inequalities
- Innovating HTA: The Role of Technology and Patient Engagement
- HTA for Medical Devices and Advanced Therapies
Who should Attend?
- Healthcare Stakeholders
- Government representatives
- Pharmaceutical industry executives (Market Access, Government Affairs, Health Economics)
- Public & Private Health services providers
- Health economists
- Academics
- Physicians
- Patient advocates & patient group representatives
Testimonials
Become a Sponsor
Download Conference Brochure 2025
Audiovisual Sponsor
CONEQ provides technical equipment and services to any kind of event. With our Simultaneous Interpretation Systems, Conference Systems, AudioVisual Equipment we support events and provide the best service to our customers. Our professionalism, our high quality of service and state of the art equipment offered to over 600 large and of great significance conferences during the last 5 years have certainly contributed to our constant uptrend. Call us at (+30) 211 2163453. or email us at [email protected]